Article

OCULUS Surgical launches ImproVue ophthalmic lubricant drops

OCULUS Surgical launched ImproVue ophthalmic lubricant drops for topical use to hydrate and lubricate the outer surface of the eye.

Chicago-OCULUS Surgical launched ImproVue ophthalmic lubricant drops for topical use to hydrate and lubricate the outer surface of the eye.

The product is a preservative-free, 1.7% hypromellose solution, packaged in single-use, sterile syringe with cannula for convenient and easy application.

More in this issue: Consensus: marijuana has no role in glaucoma management

“There is a strong demand among our customer base of vitreoretinal surgeons for a preservative-free product that is indicated for topical use to hydrate and lubricate the outer surface of the eye,” said Ron Gilliland, president and chief executive officer, OCULUS Surgical.

The lubricant eye drops are available now for shipping to customers in the United States, according to the company. 

 

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Shehzad Batliwala, DO, aka Dr. Shehz, discussed humanitarian ophthalmology and performing refractive surgery in low-resource, high-risk areas at the ASCRS Foundation Symposium.
(Image credit: Ophthalmology Times) ASCRS 2025: Advancing vitreous care with Inder Paul Singh, MD
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
© 2025 MJH Life Sciences

All rights reserved.